| Acute phase reactants in infections: evidence-based review and a guide for clinicians A Markanday Open forum infectious diseases 2 (3), ofv098, 2015 | 313 | 2015 |
| Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults C Cooper, A Thorne, M Klein, B Conway, G Boivin, D Haase, S Shafran, ... PloS one 6 (3), e17758, 2011 | 52 | 2011 |
| Diagnosing diabetic foot osteomyelitis: narrative review and a suggested 2-step score-based diagnostic pathway for clinicians A Markanday Open forum infectious diseases 1 (2), ofu060, 2014 | 46 | 2014 |
| The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus B Nosyk, B Sharif, H Sun, C Cooper, AH Anis, ... PloS one 6 (12), e27059, 2011 | 20 | 2011 |
| Ebola virus JW King, A Markanday eMedicine. WebMd. Retrieved, 10-06, 2008 | 8 | 2008 |
| Influenza vaccine Oculorespiratory syndrome incidence is reduced in HIV C Cooper, A Thorne, ... Vaccine 29 (45), 7876-7877, 2011 | 2 | 2011 |
| Cryptococcosis. eMedicine. Last updated 26 May 2005 JW King, A Markanday, A Khan | 2 | |
| Preliminary report: Efficacy of high dose daily induction interferon alpha-2b plus ribavirin followed by continuing daily interferon alpha-2b plus ribavirin in the treatment of … JW King, DR Favrot, A Markanday Hepatology 30 (4), 629A-629A, 1999 | 1 | 1999 |
| Improved clinical and virologic response is achieved with daily interferon alpha-2b plus ribavirin in the therapy of treatment-naive hepatitis C patients, and terminates … JW King, A Markanday, AA Khan, DR Favrot, AC Vanderburg, L Stevens, ... CLINICAL INFECTIOUS DISEASES 31 (1), 319-319, 2000 | | 2000 |
